Intimation for re-classification of shareholders from Promoter group to public category
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anuh Pharma's Board Meeting approved Q4 and FY26 results showing revenue of Rs. 7,760 crore (full year) and PAT of Rs. 410 crore. The company recommended a dividend of Rs. 1.50 per share (30% payout). Nine shareholders holding 9,49,988 shares (0.95% stake) from the Promoter Group have requested re-classification to Public category under SEBI regulations. This is separate from the 1:1 bonus issue (5,01,12,000 shares) allotted in July 2025. The 66th AGM is scheduled for August 12, 2026.
The promoter re-classification requests signal a reduction in perceived promoter group influence; however, with only 0.95% involved, the impact on control structure is minimal. The dividend declaration and stable financials are positive for income-focused investors.